Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Ann Rheum Dis. 2019 Jun 22;79(10):e124. doi: 10.1136/annrheumdis-2019-215843

Figure 1.

Figure 1

Mortality of patients with RA compared to the general population, stratified for follow-up duration (A), disease subset characterized by ACPA-status (B), early intensive treatment (IT) (C) and these variables combined (D&E), showing that excess mortality has normalized by early intensive treatment in ACPA-negative RA but not in ACPA-positive RA.